Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/27047
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Deniz, Nahide Gülşah | - |
dc.contributor.author | İbiş, Cemil | - |
dc.contributor.author | Gökmen, Zeliha | - |
dc.contributor.author | Stasevych, Maryna | - |
dc.contributor.author | Novikov, Volodymyr | - |
dc.contributor.author | Porokhnyavets, Olena Komarovska | - |
dc.contributor.author | Özyürek, Mustafa | - |
dc.contributor.author | Güçlü, Kubilay | - |
dc.date.accessioned | 2022-06-10T12:38:56Z | - |
dc.date.available | 2022-06-10T12:38:56Z | - |
dc.date.issued | 2015-12 | - |
dc.identifier.citation | Deniz, N. G. vd. (2015). "Design, synthesis, biological evaluation, and antioxidant and cytotoxic activity of heteroatom-substituted 1,4-naphtho- and benzoquinones". Chemical and Pharmaceutical Bulletin, 63(12), 1029-1039. | en_US |
dc.identifier.issn | 0009-2363 | - |
dc.identifier.uri | https://doi.org/10.1248/cpb.c15-00607 | - |
dc.identifier.uri | https://www.jstage.jst.go.jp/article/cpb/63/12/63_c15-00607/_article | - |
dc.identifier.uri | http://hdl.handle.net/11452/27047 | - |
dc.description.abstract | In the present paper, we report the synthesis, characterization, and biological evaluation as antifungal, antibacterial, antioxidant, and cytotoxic/anticancer agents of N-, S-, O-substituted-1,4-naphtho- and 2,5-bis(amino-substituted)-1,4-benzoquinone derivatives. In the synthesized compounds, antimicrobial activity at low concentrations against Escherichia coli B-906, Staphylococcus aureus 209-P, and Mycobacterium luteum B-917 bacteria and Candida tennis VKM Y-70 and Aspergillus niger F-1119 fungi in comparison with controls was identified. 2-(N-Diphenylmethylpiperazin-1-yl)-3-chloro-1,4-naphthoquinone 9a was the most potent, with a minimum inhibitory concentration value of 3.9, mu g/mL against test culture M. luteum. The synthesized compounds were screened for their antioxidant capacity using the cupric-reducing antioxidant capacity (CUPRAC) method. 2,2'-[1-(2-Aminoethyl)piperazin-1-yl]-3,3'-dichloro-bis(1,4-naphthoquinone) 10 showed the highest antioxidant capacity, with a 0.455 CUPRAC-trolox equivalent antioxidant capacity (TEAC) coefficient. Other parameters of antioxidant activity (scavenging effects on OH center dot, O-2(center dot-), and H2O2) of these compounds were also determined. The cytotoxic activity of the compounds was investigated by employing the sulforhodamine B cell viability assay against A549 (lung), MCF-7 (breast), DU145 (prostate), and HT-29 (colon) cancer cell lines. Compound 10 exhibited the most powerful cytotoxic activity at a concentration of 20 mu m against all cell lines. In addition to the strongest antioxidant activity of compound 10, it also had lowest IC50 values (<3 mu m), warranting further in vivo studies due to its anticancer activity. | en_US |
dc.description.sponsorship | İstanbul Üniversitesi (NP-45621) | tr_TR |
dc.language.iso | en | en_US |
dc.publisher | Pharmaceutical Soc Japan | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Antimicrobial activity | en_US |
dc.subject | Antioxidant activity | en_US |
dc.subject | Cupric-reducing antioxidant capacity method | en_US |
dc.subject | Cytotoxicity | en_US |
dc.subject | Quinone | en_US |
dc.subject | Reactive oxygen species-scavenging activity | en_US |
dc.subject | Radical radical scavenging activity | en_US |
dc.subject | Naphthoquinone derivatives | en_US |
dc.subject | Antifungal activity | en_US |
dc.subject | Spectral properties | en_US |
dc.subject | Anticancer agents | en_US |
dc.subject | Mechanisms | en_US |
dc.subject | Inhibitors | en_US |
dc.subject | Qsar | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject | Chemistry | en_US |
dc.subject.mesh | Anti-bacterial agents | en_US |
dc.subject.mesh | Antifungal agents | en_US |
dc.subject.mesh | Antineoplastic agents | en_US |
dc.subject.mesh | Antioxidants | en_US |
dc.subject.mesh | Aspergillus niger | en_US |
dc.subject.mesh | Benzoquinones | en_US |
dc.subject.mesh | Candida | en_US |
dc.subject.mesh | Cell line, tumor | en_US |
dc.subject.mesh | Cell survival | en_US |
dc.subject.mesh | Dose-responser relationship drug | en_US |
dc.subject.mesh | Drug design | en_US |
dc.subject.mesh | Drug screening assays, antitumor | en_US |
dc.subject.mesh | Escherichia coli | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Microbial sensitivity tests | en_US |
dc.subject.mesh | Molecular structure | en_US |
dc.subject.mesh | Mycobacterium | en_US |
dc.subject.mesh | Naphthoquinones | en_US |
dc.subject.mesh | Staphylococcus aureus | en_US |
dc.subject.mesh | Structure-activity relationship | en_US |
dc.title | Design, synthesis, biological evaluation, and antioxidant and cytotoxic activity of heteroatom-substituted 1,4-naphtho- and benzoquinones | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000365694900007 | tr_TR |
dc.identifier.scopus | 2-s2.0-84955461213 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Biyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Klinik Biyokimya Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-3781-6834 | tr_TR |
dc.identifier.startpage | 1029 | tr_TR |
dc.identifier.endpage | 1039 | tr_TR |
dc.identifier.volume | 63 | tr_TR |
dc.identifier.issue | 12 | tr_TR |
dc.relation.journal | Chemical and Pharmaceutical Bulletin | en_US |
dc.contributor.buuauthor | Karakaş, Didem | - |
dc.contributor.buuauthor | Ulukaya, Engin | - |
dc.contributor.researcherid | L-6682-2018 | tr_TR |
dc.contributor.researcherid | K-5792-2018 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.identifier.pubmed | 26633024 | tr_TR |
dc.subject.wos | Chemistry, medicinal | en_US |
dc.subject.wos | Chemistry, multidisciplinary | en_US |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.wos.quartile | Q3 (Chemistry, multidisciplinary) | en_US |
dc.contributor.scopusid | 56422040600 | tr_TR |
dc.contributor.scopusid | 6602927353 | tr_TR |
dc.subject.scopus | Cytotoxicity; Naphthoquinones; Quinones | en_US |
dc.subject.emtree | 2 (1 ethylsulfanyl) 3 (1 n diphenylmethylpiperazin 1 yl) 1,4 naphthoquinone | en_US |
dc.subject.emtree | 2 (n diphenylmethylpiperazin 1 yl) 3 chloro 1,4 naphthoquinone | en_US |
dc.subject.emtree | 2 [1 piperonylpiperazin 1 yl] 3 chloro 1,4 naphthoquinone | en_US |
dc.subject.emtree | 2 [4 (2 aminoethyl)morpholin 1 yl] 3 chloro 1,4 naphthoquinone | en_US |
dc.subject.emtree | 2(n diphenylmethylpiperazin 1 yl) 3 benzylsulfanyl 1,4 naphthoquinone | en_US |
dc.subject.emtree | 2,2' [1 (2 aminoethyl)piperazin 1 yl] 3,3' dichloro bis(1,4 naphthoquinone | en_US |
dc.subject.emtree | 2,3 bis(benzylsulfanyl) 1,4 naphthoquinon | en_US |
dc.subject.emtree | 2,5 bis[1 piperonylpiperazin 1 yl] 3,6 dichloro 1,4 benzoquinone | en_US |
dc.subject.emtree | 2,5 bis[4 (2 aminoethyl)morpholin 1 yl] 3,6 dichloro 1,4 benzoquinone | en_US |
dc.subject.emtree | Antiinfective agent | en_US |
dc.subject.emtree | Antioxidant | en_US |
dc.subject.emtree | Benzoquinone derivative | en_US |
dc.subject.emtree | Cytotoxic agent | en_US |
dc.subject.emtree | Hydrogen peroxide | en_US |
dc.subject.emtree | Naphthalene derivative | en_US |
dc.subject.emtree | Nystatin | en_US |
dc.subject.emtree | Reactive oxygen metabolite | en_US |
dc.subject.emtree | Sulforhodamine B | en_US |
dc.subject.emtree | Superoxide | en_US |
dc.subject.emtree | Unclassified drug | en_US |
dc.subject.emtree | Vancomycin | en_US |
dc.subject.emtree | Antifungal agent | en_US |
dc.subject.emtree | Antiinfective agent | en_US |
dc.subject.emtree | Antineoplastic agent | en_US |
dc.subject.emtree | Antioxidant | en_US |
dc.subject.emtree | Benzoquinone derivative | en_US |
dc.subject.emtree | Naphthoquinone | en_US |
dc.subject.emtree | Antibacterial activity | en_US |
dc.subject.emtree | Antifungal activity | en_US |
dc.subject.emtree | Antineoplastic activity | en_US |
dc.subject.emtree | Antioxidant activity | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Aspergillus niger | en_US |
dc.subject.emtree | Bacterium culture | en_US |
dc.subject.emtree | Cancer cell line | en_US |
dc.subject.emtree | Candida | en_US |
dc.subject.emtree | Candida tenuis | en_US |
dc.subject.emtree | Carbon nuclear magnetic resonance | en_US |
dc.subject.emtree | Cell viability assay | en_US |
dc.subject.emtree | Concentration response | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Cytotoxicity assay | en_US |
dc.subject.emtree | Dilution | en_US |
dc.subject.emtree | Drug design | en_US |
dc.subject.emtree | Drug synthesis | en_US |
dc.subject.emtree | Escherichia coli | en_US |
dc.subject.emtree | Fourier transform infrared photoacoustic spectroscopy | en_US |
dc.subject.emtree | Fourier transformation | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human cell | en_US |
dc.subject.emtree | IC50 | en_US |
dc.subject.emtree | In vivo study | en_US |
dc.subject.emtree | Mass spectrometry | en_US |
dc.subject.emtree | MCF 7 cell line | en_US |
dc.subject.emtree | Minimum inhibitory concentration | en_US |
dc.subject.emtree | Mycobacterium | en_US |
dc.subject.emtree | Mycobacterium luteum | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Proton nuclear magnetic resonance | en_US |
dc.subject.emtree | Staphylococcus aureus | en_US |
dc.subject.emtree | Structure activity relation | en_US |
dc.subject.emtree | Ultraviolet spectroscopy | en_US |
dc.subject.emtree | Cell survival | en_US |
dc.subject.emtree | Chemical structure | en_US |
dc.subject.emtree | Chemistry | en_US |
dc.subject.emtree | Dose response | en_US |
dc.subject.emtree | Drug design | en_US |
dc.subject.emtree | Drug effects | en_US |
dc.subject.emtree | Drug screening | en_US |
dc.subject.emtree | Microbial sensitivity test | en_US |
dc.subject.emtree | Synthesis | en_US |
dc.subject.emtree | Tumor cell line | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Karakaş_vd_2015.pdf | 907.35 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License